Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Pathol ; 187(6): 1230-1237, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28527710

ABSTRACT

Recent studies implicate the Cyr61, CTGF, Nov (CCN) matricellular signaling protein family as emerging players in vascular biology, with NOV (alias CCN3) as an important regulator of vascular homeostasis. Herein, we examined the role of CCN3 in the pathogenesis of atherosclerosis. In response to a 15-week high-fat diet feeding, CCN3-deficient mice on the atherosclerosis-prone Apoe-/- background developed increased aortic lipid-rich plaques compared to control Apoe-/- mice, a result that was observed in the absence of alterations in plasma lipid content. To address the cellular contributor(s) responsible for the atherosclerotic phenotype, we performed bone marrow transplantation experiments. Transplantation of Apoe; Ccn3 double-knockout bone marrow into Apoe-/- mice resulted in an increase of atherosclerotic plaque burden, whereas transplantation of Apoe-/- marrow to Apoe; Ccn3 double-knockout mice caused a reduction of atherosclerosis. These results indicate that CCN3 deficiency, specifically in the bone marrow, plays a major role in the development of atherosclerosis. Mechanistically, cell-based studies in isolated peritoneal macrophages demonstrated that CCN3 deficiency leads to an increase of lipid uptake and foam cell formation, an effect potentially attributed to the increased expression of scavenger receptors CD36 and SRA1, key factors involved in lipoprotein uptake. These results suggest that bone marrow-derived CCN3 is an essential regulator of atherosclerosis and point to a novel role of CCN3 in modulating lipid accumulation within macrophages.


Subject(s)
Atherosclerosis/metabolism , Foam Cells/metabolism , Macrophages, Peritoneal/metabolism , Nephroblastoma Overexpressed Protein/physiology , Adaptor Proteins, Signal Transducing/metabolism , Animals , Aorta/metabolism , Aorta/pathology , Atherosclerosis/etiology , Atherosclerosis/pathology , Atherosclerosis/prevention & control , Bone Marrow/metabolism , Bone Marrow Transplantation , CD36 Antigens/metabolism , Cells, Cultured , Diet, High-Fat/adverse effects , Disease Progression , Foam Cells/pathology , Lipid Metabolism/physiology , Macrophages, Peritoneal/pathology , Male , Mice, Inbred C57BL , Mice, Knockout , Nephroblastoma Overexpressed Protein/deficiency
2.
Osteoarthritis Cartilage ; 23(4): 607-15, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25541297

ABSTRACT

OBJECTIVE: The matricellular protein NOV/CCN3, is implicated in osteoarthritis (OA) and targeted mutation of NOV in mice (Nov(del3)) leads to joint abnormalities. This investigation tested whether NOV is required for joint homeostasis and if its disruption causes joint degeneration. METHOD: NOV expression in the adult mouse joint was characterized by immunohistochemistry. A detailed comparison of the joints of Nov(del3)-/- and Nov(del3)+/+ (wild-type) males and females at 2, 6 and 12 months of age was determined by X-ray, histology and immunohistochemistry. RESULTS: NOV protein was found in specific cells in articular cartilage, meniscus, synovium and ligament attachment sites in adult knees. Nov(del3)-/- males exhibited severe OA-like pathology at 12 months (OARSI score 5.0 ± 0.5, P < 0.001), affecting all tissues of the joint: erosion of the articular cartilage, meniscal enlargement, osteophytic outgrowths, ligament degeneration and expansion of fibrocartilage. Subchondral sclerosis and changes in extracellular matrix composition consistent with OA, were also seen. The density of articular cartilage cells in Nov(del3)+/+ knee joints is maintained at a constant level from 2 to 12 months of age whereas this is not the case in Nov(del3)-/- mice. Compared with age and sex-matched Nov(del3)+/+ mice, a significant increase in articular cartilage density was seen in Nov(del3)-/- males at 2 months, whereas a significant decrease was seen at 6 and 12 months in both Nov(del3)-/- males and females. CONCLUSION: NOV is required for the maintenance of articular cartilage and for joint homeostasis, with disruption of NOV in ageing Nov(del3)-/- male mice causing OA-like disease.


Subject(s)
Homeostasis/physiology , Knee Joint/physiopathology , Mutation/genetics , Nephroblastoma Overexpressed Protein/genetics , Nephroblastoma Overexpressed Protein/physiology , Osteoarthritis/physiopathology , Aging/genetics , Aging/physiology , Animals , Apoptosis/genetics , Apoptosis/physiology , Cartilage, Articular/pathology , Cartilage, Articular/physiopathology , Cell Count , Cell Proliferation/genetics , Cell Proliferation/physiology , Disease Models, Animal , Female , Homeostasis/genetics , Knee Joint/diagnostic imaging , Knee Joint/pathology , Male , Mice , Mice, Knockout , Nephroblastoma Overexpressed Protein/deficiency , Osteoarthritis/genetics , Radiography , Risk Factors
3.
Arterioscler Thromb Vasc Biol ; 30(4): 675-82, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20139355

ABSTRACT

OBJECTIVE: CCN3 belongs to the CCN family, which constitutes multifunctional secreted proteins that act as matrix cellular regulators. We investigated the pathophysiological roles of CCN3 in the vessels. METHODS AND RESULTS: We examined the effects of CCN3 on the proliferation and migration of rat vascular smooth muscle cells (VSMC). CCN3 knockout mice were created, and vascular phenotypes and neointimal hyperplasia induced by photochemically induced thrombosis were investigated. CCN3 suppressed the VSMC proliferation induced by fetal bovine serum. The neutralizing antibody for transforming growth factor-beta did not affect the growth inhibitory effect of CCN3. Moreover, CCN3 enhanced the mRNA expression of cyclin-dependent kinase inhibitors, p21 and p15. Gamma secretase inhibitor, an inhibitor of Notch signaling, partially inhibited the enhanced expression of p21 induced by CCN3. CCN3 also inhibited the VSMC migration. Finally, the histopathologic evaluation of the arteries 21 days after the endothelial injury revealed a 6-fold enhancement of neointimal thickening in the null mice compared with the wild-type mice. CONCLUSIONS: CCN3 suppresses neointimal thickening through the inhibition of VSMC migration and proliferation. Our findings indicate the involvement of CCN3 in vascular homeostasis, especially on injury, and the potential usefulness of this molecule in the modulation of atherosclerotic vascular disease.


Subject(s)
Cell Movement , Cell Proliferation , Diabetic Angiopathies/metabolism , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Nephroblastoma Overexpressed Protein/metabolism , Thrombosis/metabolism , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Amyloid Precursor Protein Secretases/metabolism , Animals , Aorta/metabolism , Aorta/pathology , Cell Cycle , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p15/metabolism , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetic Angiopathies/pathology , Diabetic Angiopathies/prevention & control , Femoral Artery/metabolism , Femoral Artery/pathology , Genotype , Hyperplasia , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/pathology , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/pathology , Nephroblastoma Overexpressed Protein/deficiency , Nephroblastoma Overexpressed Protein/genetics , Phenotype , Protease Inhibitors/pharmacology , Rats , Rats, Wistar , Receptors, Notch/metabolism , Recombinant Proteins/metabolism , Signal Transduction , Thrombosis/pathology , Thrombosis/prevention & control , Time Factors , Transfection , Transforming Growth Factor beta/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...